|
Re: review article on her2+ER+ subtypes, treatment response
Interesting. I'm not very well at the moment, (not cancer related as far as I know) so I have trouble reading the whole article. I'm wondering how this would translate to non-metastatic disease.
Jacqueline
__________________
Diagnosed age 44, January 2004, 0.7 cm IDC & DCIS. Stage 1, grade 3, ER/PR pos. HER2 pos. clear margins, no nodes. SNB. 35 rads. On Zoladex and Armidex since Dec. 2004. Stopped Zoladex/Arimidex sept 2009 Still taking mistletoe shots (CAM therapy) Doing fine.
|